Stanley C. Jordan, MD
4.8
4.8
Languages
- English,
Gender
Male
Experience
50 Years
Locations
Los Angeles
34.0769926 -118.3861037Los Angeles
Experience
Specialties
Area in which a healthcare provider is highly trained and often board certified.
2
- Peds - Nephrology
- IM Nephrology
Programs
Cedars-Sinai clinical programs this provider is part of:
3
Titles
- Director, Division of Nephrology
- Director, Nephrology
- Director, HLA and Transplant Immunology Laboratory
- Medical Director, Human Leukocyte Antigen and Transplant Immunology Laboratory
- Medical Director, Kidney Transplant Program
- Medical Director, Kidney Transplant Program
- Professor, Medicine
Education & Training
-
UCLA
Residency - Completed 1976
-
UCLA
Internship - Completed 1974
-
University of North Carolina
Medical School - Completed 1973
Achievements
-
3
Board Certifications
-
9
Awards and Honors
Board Certifications
-
Pediatrics
American Board of Pediatrics
-
Peds - Nephrology
American Board of Pediatrics
-
Diagnostic Laboratory Immunology
American Board of Pediatrics
Awards and Honors
- Prize for Research In Scientific Medicine (PRISM)
- UCLA Alumni Association Medical Science Award
- American Society of Nephrology
- American Society of Immunology
- Pioneer in Medicine Award
- American Society of Transplantation
- Established Clinical Investigator Award, American Society of Transplantation
- Outstanding Clinical Investigator Award, Western Society for Clinical Investigation
- National Kidney Foundation Gift of Life Award
Publications
- Yang T, Nast CC, Vo A, Jordan SC: Rapid remission of steroid and mycophenolate mofetil (mmf)-resistant minimal change nephrotic syndrome after rituximab therapy. Nephrol. Dial. Transplant., 23(1): 377-80, 2007
- Wu GD, He Y, Chai NN, Toyoda M, Dunn R, Kehry MR, Klein AS, Jordan SC: Anti-CD20 antibody suppresses anti-HLA antibody formation in a HLA-A2 transgenic mouse model of sensitization. Transpl. Immunol., 19(3-4): 178-86, 2008
- Wechsler E, Yang T, Jordan SC, Vo A, Nast CC: Anti-glomerular basement membrane disease in an HIV-infected patient. Nature clinical practice. Nephrology, 4(3): 167-71, 2008
- Vo AA, Wechsler EA, Wang J, Peng A, Toyoda M, Lukovsky M, Reinsmoen N, Jordan SC: Analysis of subcutaneous (SQ) alemtuzumab induction therapy in highly sensitized patients desensitized with IVIG and rituximab. Am. J. Transplant., 8(1): 144-9, 2007
- Vo AA, Lukovsky M, Toyoda M, Wang J, Reinsmoen NL, Lai CH, Peng A, Villicana R, Jordan SC: Rituximab and intravenous immune globulin for desensitization during renal transplantation. N. Engl. J. Med., 359(3): 242-51, 2008
- Toyoda M, Moudgil A, Warady BA, Puliyanda DP, Jordan SC: Clinical significance of peripheral blood Epstein-Barr viral load monitoring using polymerase chain reaction in renal transplant recipients. Pediatric transplantation, , 2008
Insurances
Before scheduling your appointment, we strongly recommend you contact your insurance company to verify that the Cedars-Sinai location or provider is included in your network.